If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

新闻稿核心观点 - 文章旨在推广Haggerston BioHealth投资研究小组的每周通讯 该通讯专注于追踪生物技术、制药和医疗保健行业股票的动态、关键趋势和估值驱动因素 [1] 服务内容与目标受众 - 提供的服务包括关注行业催化剂、给出买卖评级、提供所有大型制药公司的产品销售额与预测、综合财务报表、贴现现金流分析和逐市场分析 [1] - 该投资研究小组面向生物科技投资领域的新手和经验丰富的投资者 [1] 分析师背景 - 分析师Edmund Ingham是一名生物技术顾问 在生物技术、医疗保健和制药领域拥有超过5年的研究经验 [1] - 分析师已汇编了超过1,000家公司的详细报告 [1]